Non-invasive prenatal testing for trisomy 21 based on analysis of cell-free fetal DNA circulating in the maternal plasma

Prenatal Diagnosis

Volumn 35, Issue 5, 2015, Pages 471-476

  Alberti, A ^a   Salomon, L J ^d   Le Lorc'h, M ^b   Couloux, A ^a   Bussieres L ^d   Goupil, S ^d   Malan, V ^b   Pelletier, E ^a   Hyon, C ^b   Vialard, F ^c   Rozenberg, P ^c   Bouhanna, P ^c   Oury, J F ^b   Schmitz, T ^b   Romana, S ^b   Weissenbach, J ^a   Vekemans, M ^b   Ville, Y ^d  

^a CENTRE NATIONAL DE SÉQUENÇAGE   (France)

^b UNIVERSITÉ PARIS DESCARTES   (France)

^c UNIVERSITÉ PARIS OUEST NANTERRE LA DÉFENSE   (France)

^d HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CIRCULAR DNA; DNA FRAGMENT; DNA;

ADULT; ARTICLE; BODY MASS; CHORION VILLUS SAMPLING; CHROMOSOME 21; CLINICAL EVALUATION; COST EFFECTIVENESS ANALYSIS; FEMALE; FIRST TRIMESTER PREGNANCY; HUMAN; HUMAN GENOME; KARYOTYPE; MATERNAL PLASMA; NON INVASIVE PROCEDURE; PRENATAL SCREENING; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; SECOND TRIMESTER PREGNANCY; SENSITIVITY AND SPECIFICITY; TRISOMY 21; VALIDATION STUDY; AMNIOCENTESIS; BLOOD; COHORT ANALYSIS; DOWN SYNDROME; KARYOTYPING; PREGNANCY; PRENATAL DIAGNOSIS; RISK ASSESSMENT;

ADULT; AMNIOCENTESIS; CHORIONIC VILLI SAMPLING; COHORT STUDIES; DNA; DOWN SYNDROME; FEMALE; HUMANS; KARYOTYPING; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PREGNANCY TRIMESTER, SECOND; PRENATAL DIAGNOSIS; PROSPECTIVE STUDIES; REAL-TIME POLYMERASE CHAIN REACTION; RISK ASSESSMENT;

EID: 84928418919     PISSN: 01973851     EISSN: 10970223     Source Type: Journal    
DOI: 10.1002/pd.4561     Document Type: Article

References (41)

1. Rosen T, D'Alton ME. Down syndrome screening in the first and second trimesters: what do the data show? Semin Perinatol 2005;29(6):367-75.
2. D'Alton M, Cleary-Goldman J. First and second trimester evaluation of risk for fetal aneuploidy: the secondary outcomes of the FASTER Trial. Semin Perinatol 2005;29(4):240-6.
3. Spencer K. Aneuploidy screening in the first trimester. Am J Med Genet Part C Semin Med Genet 2007;145c:18-32.
4. Palomaki GE, Steinort K, Knight GJ, Haddow JE. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers. Obstet Gynecol 2006 Feb;107(2 Pt 1):367-75.
5. Tabor A, Alfirevic Z. Update on procedure-related risks for prenatal diagnosis techniques. Fetal Diagn Ther 2010;27(1):1-7.
6. Mujezinovic F, Alfirevic Z. Procedure-related complications of amniocentesis and chorionic villous sampling: a systematic review. Obstet Gynecol 2007;110(3):687.
7. Akolekar R, et al. Procedure related risk of miscarriage following amniocentesis and chorionic villus sampling: a systematic review and meta-analysis. Ultrasound Obstet Gynecol 2015;45:16-26. doi:10.1002/uog.14636.
8. Chiu RWK, Chan KCA, Gao Y, et al. Noninvasive prenatal diagnosis of fetal chromosomal aneuploidy by massively parallel genomic sequencing of DNA in maternal plasma. Proc Natl Acad Sci 2008;105(51):20458-63.
9. Fan HC, Blumenfeld YJ, Chitkara U, et al. Noninvasive diagnosis of fetal aneuploidy by shotgun sequencing DNA from maternal blood. Proc Natl Acad Sci U S A 2008;105(42):16266-71.
10. Chiu RWK, Akolekar R, Zheng YWL, et al. Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 2011;342:c7401.
11. Susman MR, Amor DJ, Muggli E, et al. Using population-based data to predict the impact of introducing noninvasive prenatal diagnosis for Down syndrome. Genet Med 2010;12(5):298-303.
12. Palomaki GE, Deciu C, Kloza EM, et al. DNA sequencing of maternal plasma reliably identifies trisomy 18 and trisomy 13 as well as Down syndrome: an international collaborative study. Genet Med 2012;14(3):296-305.
13. Palomaki GE, Kloza EM, Lambert-Messerlian GM, et al. DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med 2011;13(11):913-20.
14. Lo YM, Lun FM, Chan KC, et al. Digital PCR for the molecular detection of fetal chromosomal aneuploidy. Proc Natl Acad Sci U S A 2007;104(32):13116-21.
15. Ehrich M, Deciu C, Zwiefelhofer T, et al. Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 2011;204(3):205.e1-11.
16. Fan HC, Quake SR. Detection of aneuploidy with digital polymerase chain reaction. Anal Chem 2007;79(19):7576-9.
17. Nicolaides KH, Syngelaki A, Ashoor G, et al. Noninvasive prenatal testing for fetal trisomies in a routinely screened first-trimester population. Am J Obstet Gynecol 2012;207(5):374.e1-6.
18. Sparks AB, Wang ET, Struble CA, et al. Selective analysis of cell-free DNA in maternal blood for evaluation of fetal trisomy. Prenat Diagn 2012a;32(1):3-9.
19. Sparks AB, Struble CA, Wang ET, et al. Noninvasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012b;206(4):319.e1-9.
20. Ashoor G, Syngelaki A, Wagner M, et al. Chromosome- selective sequencing of maternal plasma cell-free DNA for first-trimester detection of trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;206(4):322.e1-5.
21. Sehnert AJ, Rhees B, Comstock D, et al. Optimal detection of fetal chromosomal abnormalities by massively parallel DNA sequencing of cell-free fetal DNA from maternal blood. Clin Chem 2011;57(7):1042-9.
22. Chen EZ, Chiu RWK, Sun H, et al. Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS One 2011;6(7):e21791.
23. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012a;119(5):890-901.
24. Li R, Yu C, Li Y, et al. SOAP2: an improved ultrafast tool for short read alignment. Bioinformatics 2009;25(15):1966-7.
25. Agarwal A, Sayres LC, Cho MK, et al. Commercial landscape of noninvasive prenatal testing in the United States: commercialization of noninvasive prenatal testing. Prenat Diagn 2013;33(6):521-31.
26. Lo YMD. Non-invasive prenatal diagnosis by massively parallel sequencing of maternal plasma DNA. Open Biol 2012;2(6):120086.
27. Benn P, Cuckle H, Pergament E. Non-invasive prenatal testing for aneuploidy: current status and future prospects. Ultrasound Obstet Gynecol 2013;42(1):15-33.
28. Hui L, Hyett J. Noninvasive prenatal testing for trisomy 21: challenges for implementation in Australia. Aust N Z J Obstet Gynaecol 2013;53(5):416-24.
29. Bianchi DW, Oepkes D, Ghidini A. Current controversies in prenatal diagnosis 1: should Non-invasive DNA Testing (NIDT) be the standard screening test for Down syndrome in all pregnant women? Prenat Diagn 2014;34(1):6-11.
30. Skirton H, Patch C. Factors affecting the clinical use of noninvasive prenatal testing: a mixed methods systematic review. Prenat Diagn 2013;33(6):532-41.
31. Van Lent M, Overbeke J, Out HJ. Recommendations for a uniform assessment of publication bias related to funding source. BMC Med Res Methodol 2013;13:120.
32. Bianchi DW, Platt LD, Goldberg JD, et al. Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 2012b;119(5):890-901.
33. Nicolaides KH, Syngelaki A, Gil M, et al. Validation of targeted sequencing of single-nucleotide polymorphisms for non-invasive prenatal detection of aneuploidy of chromosomes 13, 18, 21, X, and Y. Prenat Diagn 2013;33(6):575-9.
34. Nicolaides KH, Wright D, Poon LC, et al. First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing. Ultrasound Obstet Gynecol 2013;42(1):41-50.
35. Zimmermann B, Hill M, Gemelos G, et al. Noninvasive prenatal aneuploidy testing of chromosomes 13, 18, 21, X, and Y, using targeted sequencing of polymorphic loci. Prenat Diagn 2012;32(13):1233-41.
36. Norton ME, Brar H, Weiss J, et al. Non- Invasive Chromosomal Evaluation (NICE) Study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 2012;207(2):137.e1-8.
37. Faas BH, de Ligt J, Janssen I, et al. Non-invasive prenatal diagnosis of fetal aneuploidies using massively parallel sequencing-by-ligation and evidence that cell-free fetal DNA in the maternal plasma originates from cytotrophoblastic cells. Expert Opin Biol Ther 2012;16:1-8.
38. Page K, Powles T, Slade MJ, et al. The importance of careful blood processing in isolation of cell-free DNA. Ann N Y Acad Sci 2006;1075:313-7.
39. Chiu RW, Poon LL, Lau TK, et al. Effects of blood-processing protocols on fetal and total DNA quantification in maternal plasma. Clin Chem 2001;47(9):1607-13.
40. Hill M, Karunaratna M, Lewis C, et al. Views and preferences for the implementation of non-invasive prenatal diagnosis for single gene disorders from health professionals in the United Kingdom. Am J Med Genet A 2013;161(7):1612-8.
41. Twiss P, Hill M, Daley R, Chitty LS. Non-invasive prenatal testing for Down syndrome. Semin Fetal Neonatal Med 2014;19(1):9-14.